225 related articles for article (PubMed ID: 9727651)
21. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
[TBL] [Abstract][Full Text] [Related]
23. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
Enright MC; McKenzie H
J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
[TBL] [Abstract][Full Text] [Related]
24. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Klugman KP
J Antimicrob Chemother; 1996 Jul; 38 Suppl A():133-40. PubMed ID: 8858479
[TBL] [Abstract][Full Text] [Related]
25. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
Geddes AM
Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of coamoxiclav and other antibiotics against S pneumoniae and H influenae from paediatric cases of acute respiratory infections.
Krishnan P; Rajendran P; Sambandan AP; Anitha C; Chavda RK; Khobragade KJ
J Indian Med Assoc; 2011 Apr; 109(4):241-2, 244. PubMed ID: 22187795
[TBL] [Abstract][Full Text] [Related]
27. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
Watanuki Y
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
[No Abstract] [Full Text] [Related]
28. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program.
Zhang Y; Zhang F; Wang H; Zhao C; Wang Z; Cao B; Du Y; Feng X; Hu Y; Hu B; Ji P; Liu Z; Liu Y; Liao W; Lu J; Sun H; Wang Z; Xu X; Xu X; Yang Q; Yu Y; Zhang R; Zhuo C
J Glob Antimicrob Resist; 2016 Jun; 5():36-41. PubMed ID: 27436464
[TBL] [Abstract][Full Text] [Related]
30. [Rational antibiotic therapy of acute upper respiratory tract infections].
Mazur E
Pol Merkur Lekarski; 2010 Nov; 29(173):304-8. PubMed ID: 21268914
[TBL] [Abstract][Full Text] [Related]
31. Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland.
Jaecklin T; Rohner P; Jacomo V; Schmidheiny K; Gervaix A
Eur J Pediatr; 2006 Jan; 165(1):3-8. PubMed ID: 16133242
[TBL] [Abstract][Full Text] [Related]
32. Macrolide resistance: an increasing concern for treatment failure in children.
Jacobs MR; Johnson CE
Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S131-8. PubMed ID: 14566999
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial treatment of sinusitis.
Bamberger DM
Semin Respir Infect; 1991 Jun; 6(2):77-84. PubMed ID: 1771306
[TBL] [Abstract][Full Text] [Related]
34. Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption.
Tyrstrup M; Melander E; Hedin K; Beckman A; Mölstad S
BMC Infect Dis; 2017 Sep; 17(1):603. PubMed ID: 28870173
[TBL] [Abstract][Full Text] [Related]
35. The crisis of resistant pathogens in respiratory tract infections--use of pharmacodynamic principles.
Palavecino EL
Am J Manag Care; 2001 Jun; 7(6 Suppl):S170-7. PubMed ID: 11424585
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
Mikucka A; Janicka G; Krawiecka D; Kochanowska J
Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
[TBL] [Abstract][Full Text] [Related]
37. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic resistance patterns among respiratory pathogens at a German university children's hospital over a period of 10 years.
Arri SJ; Fluegge K; Mueller U; Berner R
Eur J Pediatr; 2006 Jan; 165(1):9-13. PubMed ID: 16133241
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance.
Richard MP; Aguado AG; Mattina R; Marre R
J Antimicrob Chemother; 1998 Feb; 41(2):207-14. PubMed ID: 9533462
[TBL] [Abstract][Full Text] [Related]
40. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens.
Alpuche C; Garau J; Lim V
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S135-8. PubMed ID: 17945468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
